This page is NEW and does not yet include all of the common claims made from the "Pfizer Documents". Keep checking back for more or create an account and start editing!
Background
"Public Health and Medical Professionals for Transparency" phmpt.org was created "solely to obtain and disseminate the data relied upon by the FDA to license COVID-19 vaccines".
FDA's FOIA department has limited resources (10 employees) and proposed to process the PHMPT FOIA request at a rate of about 500 pages per month.
At the time the court decision ordered FDA to deliver faster, they had already been delivering documents to the PHMPT at a far faster rate AND the PHMPT had control over which documents would be prioritized, so it is disingenuous to claim that there was ever a time when any documents were "hidden".
Due to the court order, the document processing was accelerated and the majority of documents have now been released. None of the documents contain any important information that was previously unknown, therefore there is no basis to claim that any documents were ever "hidden".
[this section needs references]
Claim: The list of side effects is 9 pages long!
Basis for claim: Pfizer document 5.3.6 Cumulative analysis of post-authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021, Appendex 1: List of Adverse Events of Special Interest
https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
Rebuttal
AESI are not side effects. AESI lists are developed by trial sponsors BEFORE a clinical trial is undertaken and lists events that should be reported by the investigator to the sponsor IF they occur.
In the same Pfizer document at section 3.1.3 (page 16):
The company’s AESI list takes into consideration the lists of AESIs from the following expert groups and regulatory authorities: Brighton Collaboration (SPEAC), ACCESS protocol, US CDC (preliminary list of AESI for VAERS surveillance), MHRA (unpublished guideline).
The AESI terms are incorporated into a TME list and include events of interest due to their association with severe COVID-19 and events of interest for vaccines in general.
The list includes items such as "Product availability issue", "Product distribution issue", "Product supply issue".
Industry Definition of Adverse Events of Special Interest:
"An adverse event of special interest (serious or non-serious) is one of scientific and medical concern specific to the sponsor’s product or programme, for which ongoing monitoring and rapid communication by the investigator to the sponsor may be appropriate."
https://cioms.ch/publications/product/development-safety-update-report-dsur-harmonizing-format-content-periodic-safety-report-clinical-trials-report-cioms-working-group-vii/
Related: Adverse Events
Basis for claim: Pfizer document 5.3.6 Cumulative analysis of post-authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021, Table 6.
https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
This is post-marketing surveillance data, NOT trial data.
The calculation seems to be computed by dividing the number of adverse events involving miscarrage (28) by the number of adverse events involving pregnancy with a known outcome (32).
The result is meaningless because we don't know how many pregnancies completed without any adverse event, and spontaneous miscarriage is very common early in pregnancy.
Also, adverse events do not imply any causal relationship with vaccination. See topic: VAERS and Adverse Event Reporting
Many studies confirm that Covid vaccines are safe for pregnancy. See topic: pregnancy-miscarriage-spontaneous-abortion
Basis for claim: Pfizer document 2.6.5 Pharmacokinetics Tabulated Summary
https://phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_26_pharmkin-tabulated-summary.pdf
This claim is discussed at Misinformation about biodistribution studies